Diabetes Foot Africa Region Registry
ConditionDiabetes
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorGetz Pharma
About this trial
D-FAR is to gather robust data on the clinical characteristics, management, and outcomes of patients with diabetic foot complications to enhance understanding, reduce complications, and improve patient care. This will include insights into the prevalence of risk factors, adherence to treatment protocols, and the effectiveness of interventions aimed at reducing the incidence of amputations and other adverse outcomes.
Eligibility criteria
Qualifiers
Male and female patients
Residents of participating African countries.
Diagnosed with diabetic foot complications (e.g., ulcers, gangrene, infection, ischemia).
Patients with a history of foot ulcers or amputations due to diabetes.
Disqualifiers
Non-diabetic foot complications.
Acute traumatic injuries unrelated to diabetes.
Patients unwilling to provide informed consent.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov